Lauren Biscaldi is the Managing Editor of Drug Topics, a publication focused on retail, community, and health systems pharmacy. With a background in pharmacy journalism, Lauren covers a wide range of topics including drug approvals, clinical updates, healthcare policies, and patient care. Her work has been featured in publications such as Patient Care, Psychiatric Times, and Dermatology Times.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Lauren's coverage predominantly focuses on healthcare and pharmaceutical topics, particularly medication-related issues. She relies heavily on data citations and government announcements in her articles.
To effectively reach out to Lauren, consider providing evidence-based insights into medication trends or developments within the healthcare industry. Experts who can provide data-driven analysis, especially related to pharmacy practices, medication access, or responses to public health crises such as the opioid epidemic or COVID-19 would likely be of interest to her.
As she does not have a specified geographic focus, pitches should appeal to an international audience and avoid localization unless it directly impacts broader industry trends.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Pharmacist inclusion in infectious disease care teams leads to better patient outcomes.
By: Lauren Biscaldi
Pharmacists can influence institutional-level climate change-related policies to ensure continued health care delivery.
Researchers evaluated the safety, feasibility, and effectiveness of intranasal fentanyl in an adult population.
A tour of modern antiretroviral and pre-exposure prophylaxis therapies included the latest updates in HIV management and prevention.
Pharmacist inclusion in infectious disease care teams leads to better patient outcomes.
Adverse events associated with triptan use can occur across multiple organ systems, including the cardiac, nervous, and gastrointestinal systems, according to research published in The Journal of Headache and Pain.
By: Lauren Biscaldi
People living with resistant or refractory migraine have a higher burden of comorbidity compared with patients with nonresistant or nonrefractory
By: Lauren Biscaldi
The FDA has added a Boxed Warning for rare but serious liver injury to the labeling of fezolinetant (Veozah), an oral neurokinin 3 receptor antagonist
By: Lauren Biscaldi
In a lawsuit unsealed on December 18, the US Department of Justice (DOJ) alleged that over the last decade, CVS knowingly filled and dispensed unlawful prescriptions in violation of the Controlled Substances Act. 1
By: Lauren Biscaldi
Although the drug fell short of its 25% expected weight loss, results are still promising for people with overweight or obesity.
(833) 317-6278 
